Prognosis and Outcome of Cerebral Sinus Venous Thrombosis—A Multicenter Cohort Study

Objectives. Cerebral sinus venous thrombosis (CSVT) is a rare stroke subtype and data regarding prognostic factors to predict outcomes are lacking. Thus, we aimed to identify predictors for outcome among CSVT patients. Materials and Methods. Prospective CSVT databases from four academic medical cent...

Full description

Saved in:
Bibliographic Details
Published in:Acta neurologica Scandinavica 2023-02, Vol.2023, p.1-7
Main Authors: Simaan, Naaem, Honig, Asaf, Hallevi, Hen, Seyman, Estelle, Rotschild, Ofer, Assayag, Einor Ben, Filioglo, Andrei, Peretz, Shlomi, Mendel, Rom, Barnea, Rani, Auriel, Eitan, Aladdin, Shorooq, Orion, David, Darawsha, Khalil, Shbat, Fadi, Leker, Ronen R., Molad, Jeremy
Format: Article
Language:English
Subjects:
Antibodies
Anticoagulants
Birth control
Cohort analysis
Coma
Diabetes
Diabetes mellitus
Etiology
Gender
Headache
Hematology
Hemorrhage
Hyperlipidemia
Hypertension
Malignancy
Medical prognosis
Mortality
Multivariate analysis
Mutation
Neurological diseases
Patients
Proteins
Risk factors
Sinuses
Statistical analysis
Stroke
Thrombosis
Tumors
Variables
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c337t-4692e209fd395587810f1f9a2648ebf628497d0683de5fcf4c990462edb222583
cites cdi_FETCH-LOGICAL-c337t-4692e209fd395587810f1f9a2648ebf628497d0683de5fcf4c990462edb222583
container_end_page 7
container_issue
container_start_page 1
container_title Acta neurologica Scandinavica
container_volume 2023
creator Simaan, Naaem
Honig, Asaf
Hallevi, Hen
Seyman, Estelle
Rotschild, Ofer
Assayag, Einor Ben
Filioglo, Andrei
Peretz, Shlomi
Mendel, Rom
Barnea, Rani
Auriel, Eitan
Aladdin, Shorooq
Orion, David
Darawsha, Khalil
Shbat, Fadi
Leker, Ronen R.
Molad, Jeremy
description Objectives. Cerebral sinus venous thrombosis (CSVT) is a rare stroke subtype and data regarding prognostic factors to predict outcomes are lacking. Thus, we aimed to identify predictors for outcome among CSVT patients. Materials and Methods. Prospective CSVT databases from four academic medical centers were retrospectively studied. Demographics, clinical presentations, risk factors, radiological, and outcome parameters were compared. Results. Out of 508 patients diagnosed with CSVT, 21 patients (4%) died, and 91 (18.6%) had unfavorable outcome (mRS≥2). Age (55.0 vs. 38.5, p
doi_str_mv 10.1155/2023/8016006
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2800896150</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2800896150</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-4692e209fd395587810f1f9a2648ebf628497d0683de5fcf4c990462edb222583</originalsourceid><addsrcrecordid>eNp9kM1KAzEURoMoWKs7HyDgUsfeZDKZZFkG_6BSobXbMD-JndJOapJBuvMhfEKfxBmma1eHC4fvwkHomsA9IUkyoUDjiQDCAfgJGvWMgAE7RSMAIBGPCTtHF95vuoumjI3Q6s3Zj8b62uO8qfC8DaXdaWwNzrTThcu3eFE3rccr3dgOy7Wzu6L3f79_pvi13Ya61E3QDmd2bV3Ai9BWh0t0ZvKt11dHjtH748Mye45m86eXbDqLyjhOQ8S4pJqCNFUsk0SkgoAhRuaUM6ELw6lgMq2Ai7jSiSkNK6UExqmuCkppIuIxuhl2985-ttoHtbGta7qXigoAITlJoLPuBqt01nunjdq7epe7gyKg-nKqL6eO5Tr9dtDXdVPlX_X_9h_09W0Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2800896150</pqid></control><display><type>article</type><title>Prognosis and Outcome of Cerebral Sinus Venous Thrombosis—A Multicenter Cohort Study</title><source>Wiley Online Library</source><source>ProQuest Publicly Available Content database</source><creator>Simaan, Naaem ; Honig, Asaf ; Hallevi, Hen ; Seyman, Estelle ; Rotschild, Ofer ; Assayag, Einor Ben ; Filioglo, Andrei ; Peretz, Shlomi ; Mendel, Rom ; Barnea, Rani ; Auriel, Eitan ; Aladdin, Shorooq ; Orion, David ; Darawsha, Khalil ; Shbat, Fadi ; Leker, Ronen R. ; Molad, Jeremy</creator><contributor>Simonsen, Claus Ziegler ; Claus Ziegler Simonsen</contributor><creatorcontrib>Simaan, Naaem ; Honig, Asaf ; Hallevi, Hen ; Seyman, Estelle ; Rotschild, Ofer ; Assayag, Einor Ben ; Filioglo, Andrei ; Peretz, Shlomi ; Mendel, Rom ; Barnea, Rani ; Auriel, Eitan ; Aladdin, Shorooq ; Orion, David ; Darawsha, Khalil ; Shbat, Fadi ; Leker, Ronen R. ; Molad, Jeremy ; Simonsen, Claus Ziegler ; Claus Ziegler Simonsen</creatorcontrib><description><![CDATA[Objectives. Cerebral sinus venous thrombosis (CSVT) is a rare stroke subtype and data regarding prognostic factors to predict outcomes are lacking. Thus, we aimed to identify predictors for outcome among CSVT patients. Materials and Methods. Prospective CSVT databases from four academic medical centers were retrospectively studied. Demographics, clinical presentations, risk factors, radiological, and outcome parameters were compared. Results. Out of 508 patients diagnosed with CSVT, 21 patients (4%) died, and 91 (18.6%) had unfavorable outcome (mRS≥2). Age (55.0 vs. 38.5, p<0.001), hypertension (26% vs. 6%, p<0.001), hyperlipidemia (23% vs. 6%, p<0.001), diabetes (17% vs. 4%, p<0.001), malignancy (35% vs. 11%, p<0.001), absence of headache (51% vs. 78%, p<0.001), focal neurological deficit (54% vs. 19%, p<0.001), and ICH (28% vs. 13%, p<0.001) were all associated with unfavorable outcome. After multivariate analysis malignancy (OR 4.2, p=0.003), the presence of focal neurological deficit (OR 5.2, p<0.001) and the presence of headache upon presentation (OR 0.334, p=0.018) remained significant predictors for favorable outcome. Conclusions. Among CSVT patients, malignancy, focal neurological deficits, and absence of headache at presentation were associated with unfavorable outcomes.]]></description><identifier>ISSN: 0001-6314</identifier><identifier>EISSN: 1600-0404</identifier><identifier>DOI: 10.1155/2023/8016006</identifier><language>eng</language><publisher>Copenhagen: Hindawi</publisher><subject>Antibodies ; Anticoagulants ; Birth control ; Cohort analysis ; Coma ; Diabetes ; Diabetes mellitus ; Etiology ; Gender ; Headache ; Hematology ; Hemorrhage ; Hyperlipidemia ; Hypertension ; Malignancy ; Medical prognosis ; Mortality ; Multivariate analysis ; Mutation ; Neurological diseases ; Patients ; Proteins ; Risk factors ; Sinuses ; Statistical analysis ; Stroke ; Thrombosis ; Tumors ; Variables ; Veins &amp; arteries</subject><ispartof>Acta neurologica Scandinavica, 2023-02, Vol.2023, p.1-7</ispartof><rights>Copyright © 2023 Naaem Simaan et al.</rights><rights>Copyright © 2023 Naaem Simaan et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-4692e209fd395587810f1f9a2648ebf628497d0683de5fcf4c990462edb222583</citedby><cites>FETCH-LOGICAL-c337t-4692e209fd395587810f1f9a2648ebf628497d0683de5fcf4c990462edb222583</cites><orcidid>0000-0003-4794-0334 ; 0000-0002-9489-0133 ; 0000-0001-7969-2932</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2800896150/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2800896150?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,44590,75126</link.rule.ids></links><search><contributor>Simonsen, Claus Ziegler</contributor><contributor>Claus Ziegler Simonsen</contributor><creatorcontrib>Simaan, Naaem</creatorcontrib><creatorcontrib>Honig, Asaf</creatorcontrib><creatorcontrib>Hallevi, Hen</creatorcontrib><creatorcontrib>Seyman, Estelle</creatorcontrib><creatorcontrib>Rotschild, Ofer</creatorcontrib><creatorcontrib>Assayag, Einor Ben</creatorcontrib><creatorcontrib>Filioglo, Andrei</creatorcontrib><creatorcontrib>Peretz, Shlomi</creatorcontrib><creatorcontrib>Mendel, Rom</creatorcontrib><creatorcontrib>Barnea, Rani</creatorcontrib><creatorcontrib>Auriel, Eitan</creatorcontrib><creatorcontrib>Aladdin, Shorooq</creatorcontrib><creatorcontrib>Orion, David</creatorcontrib><creatorcontrib>Darawsha, Khalil</creatorcontrib><creatorcontrib>Shbat, Fadi</creatorcontrib><creatorcontrib>Leker, Ronen R.</creatorcontrib><creatorcontrib>Molad, Jeremy</creatorcontrib><title>Prognosis and Outcome of Cerebral Sinus Venous Thrombosis—A Multicenter Cohort Study</title><title>Acta neurologica Scandinavica</title><description><![CDATA[Objectives. Cerebral sinus venous thrombosis (CSVT) is a rare stroke subtype and data regarding prognostic factors to predict outcomes are lacking. Thus, we aimed to identify predictors for outcome among CSVT patients. Materials and Methods. Prospective CSVT databases from four academic medical centers were retrospectively studied. Demographics, clinical presentations, risk factors, radiological, and outcome parameters were compared. Results. Out of 508 patients diagnosed with CSVT, 21 patients (4%) died, and 91 (18.6%) had unfavorable outcome (mRS≥2). Age (55.0 vs. 38.5, p<0.001), hypertension (26% vs. 6%, p<0.001), hyperlipidemia (23% vs. 6%, p<0.001), diabetes (17% vs. 4%, p<0.001), malignancy (35% vs. 11%, p<0.001), absence of headache (51% vs. 78%, p<0.001), focal neurological deficit (54% vs. 19%, p<0.001), and ICH (28% vs. 13%, p<0.001) were all associated with unfavorable outcome. After multivariate analysis malignancy (OR 4.2, p=0.003), the presence of focal neurological deficit (OR 5.2, p<0.001) and the presence of headache upon presentation (OR 0.334, p=0.018) remained significant predictors for favorable outcome. Conclusions. Among CSVT patients, malignancy, focal neurological deficits, and absence of headache at presentation were associated with unfavorable outcomes.]]></description><subject>Antibodies</subject><subject>Anticoagulants</subject><subject>Birth control</subject><subject>Cohort analysis</subject><subject>Coma</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Etiology</subject><subject>Gender</subject><subject>Headache</subject><subject>Hematology</subject><subject>Hemorrhage</subject><subject>Hyperlipidemia</subject><subject>Hypertension</subject><subject>Malignancy</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Multivariate analysis</subject><subject>Mutation</subject><subject>Neurological diseases</subject><subject>Patients</subject><subject>Proteins</subject><subject>Risk factors</subject><subject>Sinuses</subject><subject>Statistical analysis</subject><subject>Stroke</subject><subject>Thrombosis</subject><subject>Tumors</subject><subject>Variables</subject><subject>Veins &amp; arteries</subject><issn>0001-6314</issn><issn>1600-0404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kM1KAzEURoMoWKs7HyDgUsfeZDKZZFkG_6BSobXbMD-JndJOapJBuvMhfEKfxBmma1eHC4fvwkHomsA9IUkyoUDjiQDCAfgJGvWMgAE7RSMAIBGPCTtHF95vuoumjI3Q6s3Zj8b62uO8qfC8DaXdaWwNzrTThcu3eFE3rccr3dgOy7Wzu6L3f79_pvi13Ya61E3QDmd2bV3Ai9BWh0t0ZvKt11dHjtH748Mye45m86eXbDqLyjhOQ8S4pJqCNFUsk0SkgoAhRuaUM6ELw6lgMq2Ai7jSiSkNK6UExqmuCkppIuIxuhl2985-ttoHtbGta7qXigoAITlJoLPuBqt01nunjdq7epe7gyKg-nKqL6eO5Tr9dtDXdVPlX_X_9h_09W0Q</recordid><startdate>20230207</startdate><enddate>20230207</enddate><creator>Simaan, Naaem</creator><creator>Honig, Asaf</creator><creator>Hallevi, Hen</creator><creator>Seyman, Estelle</creator><creator>Rotschild, Ofer</creator><creator>Assayag, Einor Ben</creator><creator>Filioglo, Andrei</creator><creator>Peretz, Shlomi</creator><creator>Mendel, Rom</creator><creator>Barnea, Rani</creator><creator>Auriel, Eitan</creator><creator>Aladdin, Shorooq</creator><creator>Orion, David</creator><creator>Darawsha, Khalil</creator><creator>Shbat, Fadi</creator><creator>Leker, Ronen R.</creator><creator>Molad, Jeremy</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0003-4794-0334</orcidid><orcidid>https://orcid.org/0000-0002-9489-0133</orcidid><orcidid>https://orcid.org/0000-0001-7969-2932</orcidid></search><sort><creationdate>20230207</creationdate><title>Prognosis and Outcome of Cerebral Sinus Venous Thrombosis—A Multicenter Cohort Study</title><author>Simaan, Naaem ; Honig, Asaf ; Hallevi, Hen ; Seyman, Estelle ; Rotschild, Ofer ; Assayag, Einor Ben ; Filioglo, Andrei ; Peretz, Shlomi ; Mendel, Rom ; Barnea, Rani ; Auriel, Eitan ; Aladdin, Shorooq ; Orion, David ; Darawsha, Khalil ; Shbat, Fadi ; Leker, Ronen R. ; Molad, Jeremy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-4692e209fd395587810f1f9a2648ebf628497d0683de5fcf4c990462edb222583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies</topic><topic>Anticoagulants</topic><topic>Birth control</topic><topic>Cohort analysis</topic><topic>Coma</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Etiology</topic><topic>Gender</topic><topic>Headache</topic><topic>Hematology</topic><topic>Hemorrhage</topic><topic>Hyperlipidemia</topic><topic>Hypertension</topic><topic>Malignancy</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Multivariate analysis</topic><topic>Mutation</topic><topic>Neurological diseases</topic><topic>Patients</topic><topic>Proteins</topic><topic>Risk factors</topic><topic>Sinuses</topic><topic>Statistical analysis</topic><topic>Stroke</topic><topic>Thrombosis</topic><topic>Tumors</topic><topic>Variables</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simaan, Naaem</creatorcontrib><creatorcontrib>Honig, Asaf</creatorcontrib><creatorcontrib>Hallevi, Hen</creatorcontrib><creatorcontrib>Seyman, Estelle</creatorcontrib><creatorcontrib>Rotschild, Ofer</creatorcontrib><creatorcontrib>Assayag, Einor Ben</creatorcontrib><creatorcontrib>Filioglo, Andrei</creatorcontrib><creatorcontrib>Peretz, Shlomi</creatorcontrib><creatorcontrib>Mendel, Rom</creatorcontrib><creatorcontrib>Barnea, Rani</creatorcontrib><creatorcontrib>Auriel, Eitan</creatorcontrib><creatorcontrib>Aladdin, Shorooq</creatorcontrib><creatorcontrib>Orion, David</creatorcontrib><creatorcontrib>Darawsha, Khalil</creatorcontrib><creatorcontrib>Shbat, Fadi</creatorcontrib><creatorcontrib>Leker, Ronen R.</creatorcontrib><creatorcontrib>Molad, Jeremy</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Publicly Available Content database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Acta neurologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simaan, Naaem</au><au>Honig, Asaf</au><au>Hallevi, Hen</au><au>Seyman, Estelle</au><au>Rotschild, Ofer</au><au>Assayag, Einor Ben</au><au>Filioglo, Andrei</au><au>Peretz, Shlomi</au><au>Mendel, Rom</au><au>Barnea, Rani</au><au>Auriel, Eitan</au><au>Aladdin, Shorooq</au><au>Orion, David</au><au>Darawsha, Khalil</au><au>Shbat, Fadi</au><au>Leker, Ronen R.</au><au>Molad, Jeremy</au><au>Simonsen, Claus Ziegler</au><au>Claus Ziegler Simonsen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognosis and Outcome of Cerebral Sinus Venous Thrombosis—A Multicenter Cohort Study</atitle><jtitle>Acta neurologica Scandinavica</jtitle><date>2023-02-07</date><risdate>2023</risdate><volume>2023</volume><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>0001-6314</issn><eissn>1600-0404</eissn><abstract><![CDATA[Objectives. Cerebral sinus venous thrombosis (CSVT) is a rare stroke subtype and data regarding prognostic factors to predict outcomes are lacking. Thus, we aimed to identify predictors for outcome among CSVT patients. Materials and Methods. Prospective CSVT databases from four academic medical centers were retrospectively studied. Demographics, clinical presentations, risk factors, radiological, and outcome parameters were compared. Results. Out of 508 patients diagnosed with CSVT, 21 patients (4%) died, and 91 (18.6%) had unfavorable outcome (mRS≥2). Age (55.0 vs. 38.5, p<0.001), hypertension (26% vs. 6%, p<0.001), hyperlipidemia (23% vs. 6%, p<0.001), diabetes (17% vs. 4%, p<0.001), malignancy (35% vs. 11%, p<0.001), absence of headache (51% vs. 78%, p<0.001), focal neurological deficit (54% vs. 19%, p<0.001), and ICH (28% vs. 13%, p<0.001) were all associated with unfavorable outcome. After multivariate analysis malignancy (OR 4.2, p=0.003), the presence of focal neurological deficit (OR 5.2, p<0.001) and the presence of headache upon presentation (OR 0.334, p=0.018) remained significant predictors for favorable outcome. Conclusions. Among CSVT patients, malignancy, focal neurological deficits, and absence of headache at presentation were associated with unfavorable outcomes.]]></abstract><cop>Copenhagen</cop><pub>Hindawi</pub><doi>10.1155/2023/8016006</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-4794-0334</orcidid><orcidid>https://orcid.org/0000-0002-9489-0133</orcidid><orcidid>https://orcid.org/0000-0001-7969-2932</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-6314
ispartof Acta neurologica Scandinavica, 2023-02, Vol.2023, p.1-7
issn 0001-6314
1600-0404
language eng
recordid cdi_proquest_journals_2800896150
source Wiley Online Library; ProQuest Publicly Available Content database
subjects Antibodies
Anticoagulants
Birth control
Cohort analysis
Coma
Diabetes
Diabetes mellitus
Etiology
Gender
Headache
Hematology
Hemorrhage
Hyperlipidemia
Hypertension
Malignancy
Medical prognosis
Mortality
Multivariate analysis
Mutation
Neurological diseases
Patients
Proteins
Risk factors
Sinuses
Statistical analysis
Stroke
Thrombosis
Tumors
Variables
Veins & arteries
title Prognosis and Outcome of Cerebral Sinus Venous Thrombosis—A Multicenter Cohort Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A50%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognosis%20and%20Outcome%20of%20Cerebral%20Sinus%20Venous%20Thrombosis%E2%80%94A%20Multicenter%20Cohort%20Study&rft.jtitle=Acta%20neurologica%20Scandinavica&rft.au=Simaan,%20Naaem&rft.date=2023-02-07&rft.volume=2023&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=0001-6314&rft.eissn=1600-0404&rft_id=info:doi/10.1155/2023/8016006&rft_dat=%3Cproquest_cross%3E2800896150%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c337t-4692e209fd395587810f1f9a2648ebf628497d0683de5fcf4c990462edb222583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2800896150&rft_id=info:pmid/&rfr_iscdi=true